Monday, May 4, 2015
- 4:48pm-5:00pm
-
Everolimus Versus Mycophenolate for Recipients of Kidney Transplants from Expanded Criteria Donors (ECD) Receiving Anti-Thymocyte Globulin and Tacrolimus
Concurrent Session: Kidney: KDPI and Non Ideal Kidneys • Room 118-AB
- 4:48pm-5:00pm
-
Impact of Cold Ischemic Time (CIT) and Distance Traveled (DT) on Shipped Kidneys in the OPTN/UNOS Kidney Paired Donation (KPD) Pilot Program (PP)
Concurrent Session: Kidney: Living Donor Issues II • Terrace IV
- 4:48pm-5:00pm
-
Incidence of CMV Viremia in Obese and Morbidly Obese Kidney Transplants Under a Low Dose Valganciclovir Prophylaxis Protocol
- 4:48pm-5:00pm
-
Induction of a Costimulation-Susceptible Repertoire: A Case for Depletional Prior to Belatacept
Concurrent Session: Kidney: Novel Agents • Terrace I-III
- 4:48pm-5:00pm
-
Predictors of Time to Recurrence and Mortality Associated With Recurrent Hepatocellular Carcinoma After Liver Transplantation
- 4:48pm-5:00pm
-
Propensity Score-Weighted Analysis of Induction Therapies in Live Donor Kidney Transplantation in Modern Immunosuppression Era
Concurrent Session: Kidney: Induction • Room 120-ABC
- 4:48pm-5:00pm
-
Socioeconomic Status of Local Vs Exported Liver Recipients and Their Donors
Concurrent Session: Disparities in Healthcare Access • Room 115-C
- 4:48pm-5:00pm
-
The Spleen Is the Primary Site for Breg Induction and Is Required for Anti-TIM-1 Mediated Tolerance
- «Previous Page
- 1
- …
- 14
- 15
- 16
- 17
- 18
- …
- 48
- Next Page»